2023-04-16 09:00:00 ET
Price is sometimes seen as an indicator of quality in equity markets. After all, if a company has excellent prospects, investors will flock to its shares, bidding them up. That's why corporations with relatively low per-share prices are often considered less secure and riskier investments.
Even so, there are exciting stocks that can be had for less than $15 per share and that could deliver solid returns to patient investors who can handle some risk and volatility. For two examples, consider Editas Medicine (NASDAQ: EDIT) and Snap (NYSE: SNAP) .
Editas Medicine is a biotech company that focuses on gene-editing therapies. Like many of its peers in this niche, Editas Medicine currently has no approved products and isn't profitable. Also, one of its candidates encountered problems in clinical trials last year.
For further details see:
2 Stocks Under $15 Per Share to Consider